Position in MRK
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$101,073,217
-$144,562 QoQ
Shares Held
786,562
-6.5% QoQ
Ownership
0.032%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
#213
of 3,768 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Tredje AP-fonden holds $928,724,025 across 9 Drug Manufacturers - General names. MRK ranks #4 (10.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
257,172 | $308,459,837 | |
| 2 | JNJ |
Johnson & Johnson
|
753,095 | $191,263,537 | |
| 3 | ABBV |
AbbVie Inc.
|
548,411 | $138,002,144 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
786,562 | $101,073,217 | |
| 5 | AMGN |
Amgen Inc
|
169,380 | $61,335,885 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
321,765 | $40,651,790 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
690,291 | $39,774,567 | |
| 8 | PFE |
Pfizer Inc
|
1,568,204 | $37,762,352 |
All Filings in MRK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $101,073,217 | 786,562 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $101,217,779 | 841,448 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $74,656,707 | 709,260 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $52,965,285 | 631,065 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $45,529,903 | 575,163 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $82,829,989 | 922,794 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $79,964,908 | 803,829 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $82,477,719 | 726,292 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $112,462,643 | 908,422 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $113,347,952 | 859,022 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $65,632,438 | 602,022 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $55,067,131 | 534,892 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $60,515,131 | 524,440 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $53,119,143 | 499,287 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $60,228,098 | 542,840 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $38,410,897 | 446,016 | Shares | Sole | 2022-11-10 | |
| 2022-03-31 | $21,513,756 | 262,203 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $20,095,237 | 262,203 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $19,694,067 | 262,203 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $20,391,527 | 262,203 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $20,213,240 | 262,203 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $21,448,195 | 262,203 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $21,749,748 | 262,203 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $20,276,166 | 262,203 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $22,105,237 | 287,305 | Shares | Sole | 2020-05-28 | |
| No filing history on record for this holder in this stock. | ||||||